News & Events
The Appliance of Science
'Biotechnology is just one area where London’s universities are leading innovation by working alongside business. (From the Sunday Times, October 21, 2007)
Full Story
UCL Advances' First Technology Forum
'The Future of Imaging: Markets, Technology and Innovative Companies': UCL Advances hosted their first event on the 'Future of Imaging' on 16th October 2007.
Full Story
UCL and Ondine Biopharma Announce Breakthrough Staphyloccocal Photodisinfection Technology
UCL Business PLC, and Ondine Biopharma Corporation (TSX: OBP; AIM: OBP) today announced an important advance in photo-disinfection technology used to kill staphylococci such as Methicillin-Resistant Staphylococcus Aureus (MRSA) - creating the most potent photodisinfection agent known today.
Full Story
UCL Business spin-out Pentraxin Therapeutics awarded grant from the Wellcome Trust Seeding Drug Discovery Initiative
Professor Mark Pepys FRS FMedSci, a leading University College London (UCL) scientist, Head of Medicine at the Hampstead Campus (Royal Free), Director of the UCL Centre for Amyloidosis and Acute Phase Proteins, and Director of Pentraxin Therapeutics Ltd, has secured a major grant to develop breakthrough therapeutics in the treatment of transthyretin amyloidosis.
Full Story
UCL enhances London Genetics' partnering capabilities
Leading experts in genetics and genomics from UCL and six other academic institutions will provide insight into available expertise and resources in London and advise on project design.
Full Story
